C18:0-d7 GM2 Ceramide

• UNSPSC Description:

  C18:0-d7 GM2 Ceramide is deuterium labeled C18:0 GM2 Ceramide[1].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Field of Research:

  Others

• Smiles:

  O[C@H]1[C@@H](O)[C@H](NC(C)=O)[C@@H](O[C@@H]2[C@H](O[C@]3(C(O)=O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@@H](O)[C@H](O[C@H]4C(O)[C@@H](O)[C@H](OC[C@@H](C(O)/C=C/CCCCCCCCCCCCC)NC(CCCCCCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)O[C@@H]4CO)O[C@@H]2CO)O[C@H]1CO

• Molecular Weight:

  1391.73

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported